
New York: Researchers at Mount Sinai's Icahn School of Medicine have discovered an allergy route that, when inhibited, activates antitumor immunity in animal models of non-small cell lung cancer (NSCLC).

New York: Researchers at Mount Sinai's Icahn School of Medicine have discovered an allergy route that, when inhibited, activates antitumor immunity in animal models of non-small cell lung cancer (NSCLC).